AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach(Mayo Clinic in Arizona), Jorge A. Marrero(University of Pennsylvania)
Cited by 4,147
Related Papers
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
|Gastroenterology|2012|589
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era
|Gastroenterology|2021|583
International Liver Transplant Society Practice Guidelines
|Transplantation|2016|440
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385